Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation

被引:69
作者
Takahashi, Mina [2 ]
Otsuka, Fumio [1 ]
Miyoshi, Tomoko [1 ]
Otani, Hiroyuki [1 ]
Goto, Junko [1 ]
Yamashita, Misuzu [1 ]
Ogura, Toshio [1 ]
Makino, Hirofumi [1 ]
Doihara, Hiroyoshi [2 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Canc & Thorac Surg, Okayama 7008558, Japan
关键词
D O I
10.1677/JOE-08-0226
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen is involved in the development and progression of breast cancer. Here, we investigated the effects of bone morphogenetic proteins (BMPs) on breast cancer cell proliferation caused by estrogen using human breast cancer MCF-7 cells. MCF-7 cells express estrogen receptors (ESR1 and ESR2), BMP receptors, and SMAD signaling molecules. Estradiol and membrane-impermeable estradiol stimulated MCF-7 cell proliferation. Estradiol also reduced mRNA levels of ESP1, aromatase, and steroid sulfatase. Treatment with BMPs and activin had no effects on MCF-7 cell proliferation. However, BMP2, BMP4, BMP6, BMP7, and activin suppressed estradiol-induced cell mitosis, with the effects of BMP6, BMP7, and activin being more prominent than those of BMP2 and BMP4. Activin decreased ESR1 mRNA expression, while BMP6 and BMP7 impaired steroid sulfatase expression in MCF-7 cells. Interestingly, SMAD1,5,8 activation elicited by BMP6 and BMP7, but not by BMP2 and BMP4, was preserved even under the exposure of a high concentration of estradiol. The difference of BMP responsiveness was likely due to the differential modulation of BMP receptor expression induced by estradiol. In this regard, estradiol decreased the expression levels of BMPR1A, BMPR1B, ACVR2A, and ACVR2B but did not affect ACVR1 and BMPRII, leading to the sustained effects of BMP6 and BMP7 in estrogen-treated MCF-7 cells. Estradiol rapidly activated MAPK phosphorylation including extracellular signal-regulated kinase 1/2, p38, and stress-activated protein kinase/c-Jun NH2-terminal kinase pathways and BMP6, BMP7, and activin preferentially inhibited estradiol-induced p38 phosphorylation. SB203580, a selective p38 MAPK inhibitor effectively suppressed estradiol-induced cell mitosis, suggesting that p38 MAPK plays a key role in estrogen-sensitive breast cancer cell proliferation. Thus, a novel interrelationship between estrogen and the breast cancer BMP system was uncovered, in which inhibitory effects of BMP6 and BMP7 on p38 signaling and steroid sulfatase expression were functionally involved in the suppression of estrogen-induced mitosis of breast cancer cells.
引用
收藏
页码:445 / 455
页数:11
相关论文
共 65 条
[1]   Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer [J].
Alarmo, EL ;
Rauta, J ;
Kauraniemi, P ;
Karhu, R ;
Kuukasjärvi, T ;
Kallioniemi, A .
GENES CHROMOSOMES & CANCER, 2006, 45 (04) :411-419
[2]  
Aoki H, 2001, J CELL SCI, V114, P1483
[3]   Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: Importance of BMP2 [J].
Arnold, SF ;
Tims, E ;
McGrath, BE .
CYTOKINE, 1999, 11 (12) :1031-1037
[4]  
BISWAS DK, 2005, SCI STKE, pPE27, DOI DOI 10.1126/STKE.2882005PE27
[5]  
Bobinac D, 2005, CROAT MED J, V46, P389
[6]  
Clement JH, 1999, INT J CANCER, V80, P250, DOI 10.1002/(SICI)1097-0215(19990118)80:2<250::AID-IJC14>3.0.CO
[7]  
2-D
[8]  
Clement JH, 2005, INT J ONCOL, V27, P401
[9]   Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer [J].
Colditz, GA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (11) :814-823
[10]   The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer [J].
Dillon, R. L. ;
White, D. E. ;
Muller, W. J. .
ONCOGENE, 2007, 26 (09) :1338-1345